Focus on acute leukemias

Cancer Cell. 2002 Jun;1(5):417-20. doi: 10.1016/s1535-6108(02)00081-8.

Authors

D Gary Gilliland¹, Martin S Tallman

Affiliation

¹ Howard Hughes Medical Institute, Brigham and Women's Hospital, and Dana-Farber Cancer Institute, Harvard Medical School, Harvard Institutes of Medicine, 4 Blackfan Circle, Room 418, Boston, Massachusetts 02115, USA. gilliland@calvin.bwh.harvard.edu

PMID: 12124171
DOI: 10.1016/s1535-6108(02)00081-8

No abstract available

Publication types

Review

MeSH terms

Acute Disease
Antineoplastic Agents / therapeutic use
Enzyme Inhibitors / therapeutic use
Humans
Leukemia* / diagnosis
Leukemia* / drug therapy
Leukemia* / epidemiology
Leukemia* / genetics

Substances

Antineoplastic Agents
Enzyme Inhibitors